Pediatric Researcher Expresses Frustration With FDA Delay On Ketamine Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
K.J.S. "Sunny" Anand, director of critical care at Le Bonheur Children's Hospital, said he has been waiting two and a half years for the agency to clear an IND for the drug.
You may also be interested in...
FDA Takes Advisory Committee Off Life Support, Adds Analgesics To Title
The Anesthetics and Life Support Drugs Advisory Committee discussed analgesics at 11 of 14 meetings during the past four years, anesthetics at three, and life support drugs at none.
FDA Takes Advisory Committee Off Life Support, Adds Analgesics To Title
The Anesthetics and Life Support Drugs Advisory Committee discussed analgesics at 11 of 14 meetings during the past four years, anesthetics at three, and life support drugs at none.
Pediatric Anesthesia Risks Require Collaborative Studies, FDA Says
No organization acting by itself can hope to study the neurological risks of anesthesia in infants and young children, the agency says.